09:03 AM EDT, 08/06/2025 (MT Newswires) -- Novavax ( NVAX ) reported Q2 net income Wednesday of $0.62 per diluted share, down from $0.99 a year earlier.

Analysts polled by FactSet expected a loss of $0.04.

Total revenue for the quarter ended June 30 was $239.2 million, down from $415.5 million a year earlier.

Analysts surveyed by FactSet expected $152.6 million.

For 2025, the company said it expects adjusted total revenue of $1 billion to $1.05 billion, up from a prior outlook of $975 million to $1.03 billion.

Analysts polled by FactSet expect $1.02 billion.

Shares of the company were up 5.5% in recent Wednesday premarket activity.